SCHEMBL5136398

SCHEMBL5136398

O=C(O)N1CCCN(C2CN(C(c3ccccc3)c3ccccc3)C2)CC1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.52
NPSR1 Q6W5P4 2/20 0.52
KDM4E B2RXH2 2/20 0.52
MAPT P10636 2/20 0.52
HPGD P15428 1/20 0.52
L3MBTL3 Q96JM7 1/20 0.51
L3MBTL1 Q9Y468 1/20 0.51
CNR1 P21554 2/20 0.48
CNR2 P34972 2/20 0.48
ALDH1A1 P00352 3/20 0.48
MAOB P27338 1/20 0.47
CHRM1 P11229 2/20 0.46
HTT P42858 1/20 0.45
CACNA2D1 P54289 2/20 0.45
CACNA1B Q00975 2/20 0.45
CACNB1 Q02641 2/20 0.45
CACNA1C Q13936 2/20 0.45
MEN1 O00255 1/20 0.45
CACNA1H O95180 1/20 0.45
OPRD1 P41143 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16099153 0.94 KMT2A (0.53) KMT2ANPSR1KDM4EMAPTHPGD
SCHEMBL3069120 0.85 L3MBTL3 (0.67) KMT2ANPSR1KDM4EMAPTHPGD
SCHEMBL6843065 0.83 KMT2A (0.70) KMT2ANPSR1KDM4EMAPTHPGD
SCHEMBL5136397 0.83 KMT2A (0.46) KMT2ANPSR1KDM4EMAPTHPGD
SCHEMBL3263017 0.82 L3MBTL3 (0.72) KMT2ANPSR1KDM4EMAPTHPGD
SCHEMBL692922 0.82 MAOB (0.71) KMT2ANPSR1KDM4EHPGDL3MBTL3
SCHEMBL493765 0.82 ALDH1A1 (0.63) KMT2ANPSR1KDM4EMAPTHPGD
SCHEMBL3764746 0.81 CACNA2D1 (0.55) KMT2ANPSR1KDM4EALDH1A1MAOB
SCHEMBL3766753 0.81 KMT2A (0.51) KMT2ANPSR1KDM4EMAPTHPGD
SCHEMBL3772656 0.81 ALDH1A1 (0.74) KMT2ANPSR1KDM4EMAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1899318-A1 NEW AZETIDINE DERIVATIVES AS NEUROKININ RECEPTOR ANTAGONISTS FOR THE TREATMENT OF GASTROINTESTINAL DISEASES AstraZeneca AB (SE) 2008-03-19 EP disclosed
WO-2006137791-A1 NEW AZETIDINE DERIVATIVES AS NEUROKININ RECEPTOR ANTAGONISTS FOR THE TREATMENT OF GASTROINTESTINAL DISEASES ASTRAZENECA AB (SE) 2006-12-28 WO disclosed